GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » Short-Term Debt

BLIS Technologies (NZSE:BLT) Short-Term Debt : NZ$0.14 Mil (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies Short-Term Debt?

BLIS Technologies's Short-Term Debt for the quarter that ended in Sep. 2024 was NZ$0.14 Mil.

BLIS Technologies's quarterly Short-Term Debt declined from Sep. 2023 (NZ$0.24 Mil) to Mar. 2024 (NZ$0.00 Mil) but then increased from Mar. 2024 (NZ$0.00 Mil) to Sep. 2024 (NZ$0.14 Mil).

BLIS Technologies's annual Short-Term Debt declined from Mar. 2022 (NZ$0.04 Mil) to Mar. 2023 (NZ$0.00 Mil) but then stayed the same from Mar. 2023 (NZ$0.00 Mil) to Mar. 2024 (NZ$0.00 Mil).


BLIS Technologies Short-Term Debt Historical Data

The historical data trend for BLIS Technologies's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies Short-Term Debt Chart

BLIS Technologies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.05 0.04 - -

BLIS Technologies Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 - 0.24 - 0.14

BLIS Technologies Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


BLIS Technologies Short-Term Debt Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


BLIS Technologies Business Description

Traded in Other Exchanges
N/A
Address
442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).

BLIS Technologies Headlines

From GuruFocus

Olstein Strategic Opportunities Fund 2014 Investor Letter

By Canadian Value Canadian Value 04-01-2015

Blount International Inc. (BLT) CEO Joshua L Collins buys 5,000 Shares

By GuruFocus Research GuruFocus Editor 06-17-2010

John Rogers Exits Blount International in 1st Quarter

By David Goodloe David Goodloe 06-12-2016

Bill Nygren's Oakmark Comments on Blount International

By Holly LaFon Holly LaFon 07-10-2012

Ariel Fund Quarterly Commentary From John Rogers

By Holly LaFon Holly LaFon 01-21-2016

John Rogers Trims Stake in Blount International

By Kyle Ferguson Kyle Ferguson 04-18-2016

Blount International Inc. (BLT) CEO Joshua L Collins buys 10,000 Shares

By GuruFocus Research GuruFocus Editor 10-13-2009

Jean-Marie Eveillard Sells More Blount International

By Holly LaFon Holly LaFon 10-09-2012